Cellosaurus logo
expasy logo

Cellosaurus NCC-MFS8-C1 (CVCL_E4BM)

[Text version]
Cell line name NCC-MFS8-C1
Accession CVCL_E4BM
Resource Identification Initiative To cite this cell line use: NCC-MFS8-C1 (RRID:CVCL_E4BM)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
Doubling time: 68 hours (PubMed=39214957).
Omics: Phenotyping; Drug screening.
Omics: Variations; SNP array analysis.
Derived from site: In situ; Right leg; UBERON=UBERON_0000978.
Sequence variations
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 79Y
Category Cancer cell line
STR profile Source(s): PubMed=39214957

Markers:
AmelogeninX
CSF1PO11,12
D5S81810,12
D7S82011
D13S31711
D16S53911
D21S1129,30
TH018,9
TPOX9,11
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=39214957; DOI=10.1007/s13577-024-01124-4
Yuki Adachi, Rei Noguchi, Julia Osaki, Takuya Ono, Shuhei Iwata, Taro Akiyama, Ryuto Tsuchiya, Yu Toda, Tetsuya Sekita, Shintaro Iwata, Eisuke Kobayashi ...Show all 16 authors... , Naoki Kojima, Akihiko Yoshida, Hideki Yokoo, Akira Kawai, Tadashi Kondo; Show fewer authors
Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1.
Hum. Cell 37:1742-1750(2024)

Entry history
Entry creation19-Dec-2024
Last entry update10-Apr-2025
Version number2